Merit Medical

Merit Medical, headquartered in the US and operating in the medical, precision and optical instruments industry, reported its Scope 1 and 2 emissions for 2025 as approximately 30,875,000 kg CO2e (market-based). This includes about 12,328,000 kg CO2e from Scope 1 emissions and approximately 18,547,000 kg CO2e from Scope 2 (market-based) emissions.

Looking back, in 2024, the company's Scope 1 and 2 emissions totalled about 22,688,000 kg CO2e, comprising around 3,106,000 kg CO2e from Scope 1 and approximately 19,582,000 kg CO2e from Scope 2 (market-based) emissions. For 2023, Merit Medical's total reported emissions were about 17,656,000 kg CO2e, with Scope 1 at approximately 3,072,000 kg CO2e and Scope 2 at about 14,584,000 kg CO2e. The company also reported some Scope 3 emissions for 'fuel and energy related activities' at approximately 8,450 kg CO2e in 2023, though overall Scope 3 data is noted as incomplete for 'purchased goods and services'.

In 2022, total emissions were around 17,239,000 kg CO2e, with Scope 1 emissions of approximately 3,101,000 kg CO2e and Scope 2 emissions of about 17,795,000 kg CO2e. In 2021, the combined Scope 1 and 2 emissions were approximately 18,200,000 kg CO2e, made up of about 3,415,000 kg CO2e from Scope 1 and around 14,785,000 kg CO2e from Scope 2. For 2020, total emissions were approximately 20,370,000 kg CO2e. This included a notable Scope 1 figure of about 3,017,000,000 kg CO2e and Scope 2 emissions of roughly 17,353,000 kg CO2e.

Merit Medical has not disclosed any specific reduction targets, including Science Based Targets (SBTi), nor has it signed the Climate Pledge.